Patents by Inventor Luca Tottone

Luca Tottone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Capsule for the preparation of a coffee-based beverage
    Patent number: 11939142
    Abstract: A capsule for extraction of a beverage of the filter-coffee type has a capsule body (2), made of water-impermeable material, which defines a chamber (3), present inside which is a precursor of the beverage, comprising soluble coffee and roast and ground coffee. At least 51 wt % of the precursor is roast and ground coffee having a grain size expressed in x50 comprised between 350 and 800 ?m, and the complement to 100 wt % of the precursor is soluble coffee having a grain size expressed in x50 comprised between 1000 and 5000 ?m. The roast and ground coffee is laid out to form a first layer (GC) in the lower part of the capsule body (3), and the soluble coffee (SC) is laid out to form a second layer (SC) in the upper part of the capsule body, i.e., in a position corresponding to the inlet wall (5) and/or above the first layer (GC).
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: March 26, 2024
    Assignee: LUIGI LAVAZZA S.P.A.
    Inventors: Fabio Tottone, Luca Bugnano, Emilio Cugnetto, Luisa Borello, Silvia Barus, Alberto Cabilli
  • NOTCH INHIBITORS FOR USE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20210363121
    Abstract: Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
    Type: Application
    Filed: August 9, 2021
    Publication date: November 25, 2021
    Inventors: Bruno Botta, Isabella Screpanti, Luca Tottone, Nadezda Zhdanoskaya, Cinzia Ingallina, Francesca Giulimondi, Deborah Quaglio, Rocco Palermo, Mattia Mori, Francesca Ghirga
  • Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia
    Patent number: 11104657
    Abstract: Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: August 31, 2021
    Assignees: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, UNIVERSITÀ DEGLI STUDI DI ROMA “LA SAPIENZA”
    Inventors: Bruno Botta, Isabella Screpanti, Luca Tottone, Nadezda Zhdanoskaya, Cinzia Ingallina, Francesca Giulimondi, Deborah Quaglio, Rocco Palermo, Mattia Mori, Francesca Ghirga
  • NOTCH INHIBITORS FOR USE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20190337916
    Abstract: Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
    Type: Application
    Filed: December 20, 2017
    Publication date: November 7, 2019
    Inventors: Bruno Botta, Isabella Screpanti, Luca Tottone, Nadezda Zhdanoskaya, Cinzia Ingallina, Francesca Giulimondi, Deborah Quaglio, Rocco Palermo, Mattia Mori, Francesca Ghirga